Individual effects of different selenocompounds on the hepatic proteome and energy metabolism of mice

Biochimica et Biophysica Acta - General Subjects

Volumn 1861, Issue 1, 2017, Pages 3323-3334

  Lennicke, Claudia ^a   Rahn, Jette ^a   Kipp, Anna P ^b   Dojčinović, Biljana P ^c   Müller, Andreas S ^a,d   Wessjohann, Ludger A ^e   Lichtenfels, Rudolf ^a   Seliger, Barbara ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^c UNIVERSITY OF BELGRADE   (Serbia)

^d Delacon Biotechnik   (Austria)

^e LEIBNIZ INSTITUTE OF PLANT BIOCHEMISTRY   (Germany)

Author keywords

Energy metabolism; Liver; Redox status; Selenium

Indexed keywords

GLUTATHIONE; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE P1; PROTEOME; SELENATE; SELENITE; SELENIUM; SELENOMETHIONINE; SELENOPROTEIN; TRANSCRIPTION FACTOR NRF2; ANTIOXIDANT; MESSENGER RNA; SELENIUM DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIETARY INTAKE; ENERGY METABOLISM; GENE EXPRESSION; LIVER; LIVER LEVEL; MALE; MASS SPECTROMETRY; MOUSE; NONHUMAN; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; BLOOD; C57BL MOUSE; DIETARY SUPPLEMENT; DRUG EFFECTS; FEEDING BEHAVIOR; GENETICS; HOMEOSTASIS; METABOLISM; OXIDATION REDUCTION REACTION; PHOSPHORYLATION; PROTEOMICS; UPREGULATION; WEIGHT GAIN;

ANIMALS; ANTIOXIDANTS; DIETARY SUPPLEMENTS; ENERGY METABOLISM; FEEDING BEHAVIOR; GLUTATHIONE; HOMEOSTASIS; LIVER; MALE; MICE, INBRED C57BL; NF-E2-RELATED FACTOR 2; OXIDATION-REDUCTION; PHOSPHORYLATION; PROTEOME; PROTEOMICS; RNA, MESSENGER; SELENIUM; SELENIUM COMPOUNDS; SELENOMETHIONINE; UP-REGULATION; WEIGHT GAIN;

EID: 84995529961     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2016.08.015     Document Type: Article

References (69)

1. [1] El-Bayoumy, K., Sinha, R., Molecular chemoprevention by selenium: a genomic approach. Mutat. Res. 591 (2005), 224–236, 10.1016/j.mrfmmm.2005.04.021.
2. [2] Vinceti, M., Crespi, C.M., Malagoli, C., Del Giovane, C., Krogh, V., Friend or foe? The current epidemiologic evidence on selenium and human cancer risk. J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev. 31 (2013), 305–341, 10.1080/10590501.2013.844757.
3. [3] Labunskyy, V.M., Hatfield, D.L., Gladyshev, V.N., Selenoproteins: molecular pathways and physiological roles. Physiol. Rev. 94 (2014), 739–777, 10.1152/physrev.00039.2013.
4. [4] Wessjohann, L.A., Schneider, A., Abbas, M., Brandt, W., Selenium in chemistry and biochemistry in comparison to sulfur. Biol. Chem. 388 (2007), 997–1006, 10.1515/BC.2007.138.
5. [5] Huang, Z., Rose, A.H., Hoffmann, P.R., The role of selenium in inflammation and immunity: from molecular mechanisms to therapeutic opportunities. Antioxid. Redox Signal. 16 (2012), 705–743, 10.1089/ars.2011.4145.
6. [6] Mueller, A.S., Mueller, K., Wolf, N.M., Pallauf, J., Selenium and diabetes: an enigma?. Free Radic. Res. 43 (2009), 1029–1059, 10.1080/10715760903196925.
7. [7] Misra, S., Boylan, M., Selvam, A., Spallholz, J.E., Björnstedt, M., Redox-active selenium compounds — from toxicity and cell death to cancer treatment. Nutrients 7 (2015), 3536–3556, 10.3390/nu7053536.
8. [8] Müller, M., Banning, A., Brigelius-Flohé, R., Kipp, A.P., Nrf2 target genes are induced under marginal selenium-deficiency. Genes Nutr. 5 (2010), 297–307, 10.1007/s12263-010-0168-8.
9. [9] Hayes, J.D., Dinkova-Kostova, A.T., The Nrf2 regulatory network provides an interface between redox and intermediary metabolism. Trends Biochem. Sci. 39 (2014), 199–218, 10.1016/j.tibs.2014.02.002.
10. [10] Steinbrenner, H., Speckmann, B., High selenium intake and increased diabetes risk: experimental evidence for interplay between selenium and carbohydrate metabolism. J. Clin. Biochem. Nutr. 48 (2011), 40–45.
11. [11] Ezaki, O., The insulin-like effects of selenate in rat adipocytes. J. Biol. Chem. 265 (1990), 1124–1128.
12. [12] Mueller, A.S., Pallauf, J., Compendium of the antidiabetic effects of supranutritional selenate doses. In vivo and in vitro investigations with type II diabetic db/db mice. J. Nutr. Biochem. 17 (2006), 548–560.
13. [13] Bleys, J., Navas-Acien, A., Guallar, E., Serum selenium and diabetes in U.S. adults. Diabetes Care 30 (2007), 829–834, 10.2337/dc06–1726.
14. [14] Laclaustra, M., Stranges, S., Navas-Acien, A., Ordovas, J.M., Guallar, E., Serum selenium and serum lipids in US adults: National Health and Nutrition Examination Survey (NHANES) 2003–2004. Atherosclerosis 210 (2010), 643–648.
15. [15] Stranges, S., Sieri, S., Vinceti, M., Grioni, S., Guallar, E., Laclaustra, M., Muti, P., Berrino, F., Krogh, V., A prospective study of dietary selenium intake and risk of type 2 diabetes. BMC Public Health, 10, 2010, 564.
16. [16] Lennicke, C., Rahn, J., Lichtenfels, R., Wessjohann, L.A., Seliger, B., Hydrogen peroxide — production, fate and role in redox signaling of tumor cells. Cell Commun. Signal., 13, 2015, 39, 10.1186/s12964-015-0118-6.
17. [17] Mueller, A.S., Klomann, S.D., Wolf, N.M., Schneider, S., Schmidt, R., Spielmann, J., Stangl, G., Eder, K., Pallauf, J., Redox regulation of protein tyrosine phosphatase 1B by manipulation of dietary selenium affects the triglyceride concentration in rat liver. J. Nutr. 138 (2008), 2328–2336, 10.3945/jn.108.089482.acid.
18. [18] Pinto, A., Juniper, D.T., Sanil, M., Morgan, L., Clark, L., Sies, H., Rayman, M.P., Steinbrenner, H., Supranutritional selenium induces alterations in molecular targets related to energy metabolism in skeletal muscle and visceral adipose tissue of pigs. J. Inorg. Biochem. 114 (2012), 47–54, 10.1016/j.jinorgbio.2012.04.011.
19. [19] Pinto, A., Speckmann, B., Heisler, M., Sies, H., Steinbrenner, H., Delaying of insulin signal transduction in skeletal muscle cells by selenium compounds. J. Inorg. Biochem. 105 (2011), 812–820.
20. [20] McClung, J.P., Roneker, C.A., Mu, W., Lisk, D.J., Langlais, P., Liu, F., Lei, X.G., Development of insulin resistance and obesity in mice overexpressing cellular glutathione peroxidase. Proc. Natl. Acad. Sci. U. S. A. 101 (2004), 8852–8857, 10.1073/pnas.0308096101.
21. [21] Loh, K., Deng, H., Fukushima, A., Cai, X., Boivin, B., Bruce, C., Shields, B.J., Skiba, B., Ooms, L.M., Stepto, N., Wu, B., Mitchell, C.A., Tonks, N.K., Watt, M.J., Febbraio, M.A., Crack, P.J., Andrikopoulos, S., Tiganis, T., Reactive oxygen species enhance insulin sensitivity. Cell Metab. 10 (2009), 260–272, 10.1016/j.cmet.2009.08.009.
22. [22] Houstis, N., Rosen, E.D., Lander, E.S., Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 440 (2006), 944–948, 10.1038/nature04634.
23. [23] Rees, K., Hartley, L., Day, C., Flowers, N., Clarke, A., Stranges, S., Selenium supplementation for the primary prevention of cardiovascular disease (review). Cochrane Database Syst. Rev., 2013, 10.1002/14651858.
24. [24] Wastney, M.E., Combs, G.F., Canfield, W.K., Taylor, P.R., Patterson, K.Y., Hill, A.D., Moler, J.E., Patterson, B.H., A human model of selenium that integrates metabolism from selenite and selenomethionine. J. Nutr. 141 (2011), 708–717, 10.3945/jn.110.129049.
25. [25] Schrauzer, G.N., Nutritional selenium supplements: product types, quality, and safety. J. Am. Coll. Nutr. 20 (2001), 1–4.
26. [26] Papp, L.V., Lu, J., Holmgren, A., Khanna, K.K., From selenium to selenoproteins: synthesis, identity, and their role in human health. Antioxid. Redox Signal. 9 (2007), 775–806, 10.1089/ars.2007.1528.
27. [27] Burk, R.F., Hill, K.E., Motley, A.K., Plasma selenium in specific and non-specific forms. Biofactors 14 (2001), 107–114.
28. [28] Burk, R.F., Hill, K.E., Regulation of selenium metabolism and transport. Annu. Rev. Nutr. 35 (2015), 109–134, 10.1146/annurev-nutr-071714-034250.
29. [29] Scharrer, E., Senn, E., Wolffram, S., Stimulation of mucosal uptake of selenium from selenite by some thiols at various sites of rat intestine. Biol. Trace Elem. Res. 33 (1992), 109–120.
30. [30] Senn, E., Scharrer, E., Wolffram, S., Effects of glutathione and of cysteine on intestinal absorption of selenium from selenite. Biol. Trace Elem. Res. 33 (1992), 103–108.
31. [31] Hirata, A., Maeda, N., Hiuge, A., Hibuse, T., Fujita, K., Okada, T., Kihara, S., Funahashi, T., Shimomura, I., Blockade of mineralocorticoid receptor reverses adipocyte dysfunction and insulin resistance in obese mice. Cardiovasc. Res. 84 (2009), 164–172, 10.1093/cvr/cvp191.
32. [32] Dufailly, V., Noël, L., Guérin, T., Determination of chromium, iron and selenium in foodstuffs of animal origin by collision cell technology, inductively coupled plasma mass spectrometry (ICP-MS), after closed vessel microwave digestion. Anal. Chim. Acta 565 (2006), 214–221, 10.1016/j.aca.2006.02.046.
33. [33] Chomczynski, P., Sacchi, N., The single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction: twenty-something years on. Nat. Protoc. 1 (2006), 581–585, 10.1038/nprot.2006.83.
34. [34] Bukur, J., Herrmann, F., Handke, D., Recktenwald, C., Seliger, B., Identification of E2F1 as an important transcription factor for the regulation of tapasin expression. J. Biol. Chem. 285 (2010), 30419–30426, 10.1074/jbc.M109.094284.
35. [35] Untergasser, A., Cutcutache, I., Koressaar, T., Ye, J., Faircloth, B.C., Remm, M., Rozen, S.G., Primer3-new capabilities and interfaces. Nucleic Acids Res., 40, 2012, e115, 10.1093/nar/gks596.
36. [36] Pfaffl, M.W., A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res., 29, 2001, e45.
37. [37] Steven, A., Leisz, S., Massa, C., Iezzi, M., Lattanzio, R., Lamolinara, A., Bukur, J., Müller, A., Hiebl, B., Holzhausen, H.-J., Seliger, B., HER-2/neu mediates oncogenic transformation via altered CREB expression and function. Mol. Cancer Res. 11 (2013), 1462–1477, 10.1158/1541-7786.MCR-13-0125.
38. [38] Lawrence, R.A., Burk, R.F., Glutathione peroxidase activity in selenium-deficient rat liver. Biochem. Biophys. Res. Commun. 71 (1976), 952–958, 10.1016/j.bbrc.2012.08.016.
39. [39] Florian, S., Krehl, S., Loewinger, M., Kipp, A., Banning, A., Esworthy, S., Chu, F.-F., Brigelius-Flohé, R., Loss of GPx2 increases apoptosis, mitosis, and GPx1 expression in the intestine of mice. Free Radic. Biol. Med. 49 (2010), 1694–1702, 10.1016/j.freeradbiomed.2010.08.029.
40. [40] Krehl, S., Loewinger, M., Florian, S., Kipp, A.P., Banning, A., Wessjohann, L.A., Brauer, M.N., Iori, R., Esworthy, R.S., Chu, F.-F., Brigelius-Flohé, R., Glutathione peroxidase-2 and selenium decreased inflammation and tumors in a mouse model of inflammation-associated carcinogenesis whereas sulforaphane effects differed with selenium supply. Carcinogenesis 33 (2012), 620–628, 10.1093/carcin/bgr288.
41. [41] Marklund, S., Marklund, G., Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur. J. Biochem. 47 (1974), 469–474.
42. [42] Habig, W.H., Pabst, M.J., Jakoby, W.B., Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J. Biol. Chem. 249 (1974), 7130–7139.
43. [43] Tipple, T.E., Rogers, L.K., Methods for the determination of plasma or tissue glutathione levels. Methods Mol. Biol. 889 (2012), 1–8, 10.1007/978-1-61779-867-2.
44. [44] Neuhoff, V., Stamm, R., Eibl, H., Clear background and highly sensitive protein staining with Coomassie blue dyes in polyacrylamide gels: a systematic analysis. Electrophoresis 6 (1985), 427–448, 10.1002/elps.1150060905.
45. [45] Lichtenfels, R., Ackermann, A., Kellner, R., Seliger, B., Mapping and expression pattern analysis of key components of the major histocompatibility complex class I antigen processing and presentation pathway in a representative human renal cell carcinoma cell line. Electrophoresis 22 (2001), 1801–1809.
46. [46] Seliger, B., Lichtenfels, R., Atkins, D., Bukur, J., Halder, T., Kersten, M., Harder, A., Ackermann, A., Malenica, B., Brenner, W., Zobawa, M., Lottspeich, F., Identification of fatty acid binding proteins as markers associated with the initiation and/or progression of renal cell carcinoma. Proteomics 5 (2005), 2631–2640, 10.1002/pmic.200401264.
47. [47] Lichtenfels, R., Mougiakakos, D., Johansson, C.C., Dressler, S.P., Recktenwald, C.V., Kiessling, R., Seliger, B., Comparative expression profiling of distinct T cell subsets undergoing oxidative stress. PLoS One, 7, 2012, e41345, 10.1371/journal.pone.0041345.
48. [48] Jasinski-Bergner, S., Stehle, F., Gonschorek, E., Kalich, J., Schulz, K., Huettelmaier, S., Braun, J., Seliger, B., Identification of 14-3-3β gene as a novel miR-152 target using a proteome-based approach. J. Biol. Chem. 289 (2014), 31121–31135, 10.1074/jbc.M114.556290.
49. [49] Brigelius-Flohé, R., Kipp, A.P., Selenium in the redox regulation of the Nrf2 and the Wnt pathway. Methods Enzymol. 527 (2013), 65–86, 10.1016/B978-0-12-405882-8.00004-0.
50. [50] Wasserman, W.W., Fahl, W.E., Functional antioxidant responsive elements. Proc. Natl. Acad. Sci. U. S. A. 94 (1997), 5361–5366.
51. [51] Rahmanto, A.S., Davies, M.J., Catalytic activity of selenomethionine in removing amino acid, peptide, and protein hydroperoxides. Free Radic. Biol. Med. 51 (2011), 2288–2299, 10.1016/j.freeradbiomed.2011.09.027.
52. [52] Rahmanto, A.S., Davies, M.J., Selenium-containing amino acids as direct and indirect antioxidants. IUBMB Life 64 (2012), 863–871, 10.1002/iub.1084.
53. [53] Burk, R.F., Hill, K.E., Nakayama, A., Mostert, V., Ximena, A., Motley, A.K., Freeman, M.L., Austin, L.M., Selenium deficiency activates mouse liver Nrf2-ARE but vitamin E deficiency does not. Free Radic. Biol. Med. 44 (2008), 1617–1623.
54. [54] Lawrence, R.A., Parkhill, L.K., Burk, R.F., Hepatic cytosolic non selenium-dependent glutathione peroxidase activity: its nature and the effect of selenium deficiency. J. Nutr. 108 (1978), 981–987.
55. [55] Hoen, P.A.C.‘’t., Rooseboom, M., Bijsterbosch, M.K., van Berkel, T.J.C., Vermeulen, N.P.E., Commandeur, J.N.M., Induction of glutathione-S-transferase mRNA levels by chemopreventive selenocysteine Se-conjugates. Biochem. Pharmacol. 63 (2002), 1843–1849.
56. [56] Henao-Mejia, J., Elinav, E., Jin, C., Hao, L., Mehal, W.Z., Strowig, T., Thaiss, C.A., Kau, A.L., Eisenbarth, S.C., Jurczak, M.J., Camporez, J.-P., Shulman, G.I., Gordon, J.I., Hoffman, H.M., Flavell, R.A., Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 482 (2012), 179–185, 10.1038/nature10809.
57. [57] Yeung, E.N.W., Treskes, P., Martin, S.F., Manning, J.R., Dunbar, D.R., Rogers, S.M., Le Bihan, T., Lockman, K.A., Morley, S.D., Hayes, P.C., Nelson, L.J., Plevris, J.N., Fibrinogen production is enhanced in an in-vitro model of non-alcoholic fatty liver disease: an isolated risk factor for cardiovascular events?. Lipids Health Dis., 14, 2015, 86, 10.1186/s12944-015-0069-3.
58. [58] Hiller, F., Oldorff, L., Besselt, K., Kipp, A.P., Differential acute effects of selenomethionine and sodium selenite on the severity of colitis. Nutrients 7 (2015), 2687–2706, 10.3390/nu7042687.
59. [59] Mueller, A.S., Bosse, A.C., Most, E., Klomann, S.D., Schneider, S., Pallauf, J., Regulation of the insulin antagonistic protein tyrosine phosphatase 1B by dietary Se studied in growing rats. J. Nutr. Biochem. 20 (2009), 235–247, 10.1016/j.jnutbio.2008.02.007.
60. [60] Xu, J.X., Cao, C.Y., Sun, Y.C., Wang, L.L., Li, N., Xu, S.W., Li, J.L., Effects on liver hydrogen peroxide metabolism induced by dietary selenium deficiency or excess in chickens. Biol. Trace Elem. Res. 159 (2014), 174–182, 10.1007/s12011-014-0002-z.
61. [61] Perrone, C.E., Malloy, V.L., Orentreich, D.S., Orentreich, N., Metabolic adaptations to methionine restriction that benefit health and lifespan in rodents. Exp. Gerontol. 48 (2013), 654–660, 10.1016/j.exger.2012.07.005.
62. [62] Maddineni, S., Nichenametla, S., Sinha, R., Wilson, R.P., Richie, J.P., Methionine restriction affects oxidative stress and glutathione-related redox pathways in the rat. Exp. Biol. Med. (Maywood) 238 (2013), 392–399, 10.1177/1535370213477988.
63. [63] Tsai, C.W., Lin, A.H., Wang, T.S., Liu, K.L., Chen, H.W., Lii, C.K., Methionine restriction up-regulates the expression of the pi class of glutathione S-transferase partially via the extracellular signal-regulated kinase-activator protein-1 signaling pathway initiated by glutathione depletion. Mol. Nutr. Food Res. 54 (2010), 841–850, 10.1002/mnfr.200900083.
64. [64] Ables, G.P., Perrone, C.E., Orentreich, D., Orentreich, N., Methionine-restricted C57BL/6J mice are resistant to diet-induced obesity and insulin resistance but have low bone density. PLoS One, 7, 2012, e51357, 10.1371/journal.pone.0051357.
65. [65] Müller, A.S., Most, E., Pallauf, J., Effects of a supranutritional dose of selenate compared with selenite on insulin sensitivity in type II diabetic dbdb mice. J. Anim. Physiol. Anim. Nutr. (Berl.) 89 (2005), 94–104, 10.1111/j.1439-0396.2005.00559.x.
66. [66] Iizuka, Y., Ueda, Y., Yagi, Y., Sakurai, E., Significant improvement of insulin resistance of GK rats by treatment with sodium selenate. Biol. Trace Elem. Res. 138 (2010), 265–271, 10.1007/s12011-010-8622-4.
67. [67] Panzhinskiy, E., Ren, J., Nair, S., Pharmacological inhibition of protein tyrosine phosphatase 1B: a promising strategy for the treatment of obesity and type 2 diabetes mellitus. Curr. Med. Chem. 20 (2013), 2609–2625.
68. [68] Salmeen, A., Andersen, J.N., Myers, M.P., Meng, T.C., Hinks, J.A., Tonks, N.K., Barford, D., Redox regulation of protein tyrosine phosphatase 1B involves a sulphenyl-amide intermediate. Nature 423 (2003), 769–773, 10.1038/nature01680.
69. [69] Hagiwara, A., Cornu, M., Cybulski, N., Polak, P., Betz, C., Trapani, F., Terracciano, L., Heim, M.H., Rüegg, M.A., Hall, M.N., Hepatic mTORC2 activates glycolysis and lipogenesis through Akt, glucokinase, and SREBP1c. Cell Metab. 15 (2012), 725–738, 10.1016/j.cmet.2012.03.015.